Jun 19 – 22, 2024
Squamish, BC, Canada
Canada/Pacific timezone
This conference is now SOLD OUT for in-person registration. Virtual registration is still available.

TRANSMISSION DYNAMICS OF HIV-1 CRF01_AE IN NEWLY DIAGNOSED AND TREATMENT-EXPERIENCED INDIVIDUALS IN INDONESIA

Not scheduled
20m
Squamish, BC, Canada

Squamish, BC, Canada

Poster Transmission dynamics & clusters

Speaker

Dr Wahyu Nawang Wulan (The Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia)

Description

Introduction
Ongoing HIV transmission is a formidable public health challenge in Indonesia, where prevalence is 0.3% and persons with HIV (PWH) are distributed across >6,000 inhabited islands over 5,000 km. Incidence is likely substantial; we estimated c.10% of newly diagnosed PWH were recent infections (Wulan et al., 2023). To identify factors responsible for contemporary HIV spread, we analyzed CRF01_AE sequences from newly diagnosed and treatment-experienced PWH in the context of demographic and clinical data.
Methods
PWH enrolled in “HIV Infection and Risk Related Coinfections / Comorbidities Study in Indonesia” (PROACTIVE; N = 4,329) were recruited from 19 sites in 16 cities, with pol sequences (1,043 bp, HXB2 2253 – 3295) obtained from plasma. HIV subtypes and drug resistance mutations (DRMs) were identified (https://hivdb.stanford.edu/), and genetic relationships were characterized (Bayesian inference; BEAST) using GenBank-derived references, including curated pol sequences from Indonesia (N = 176) and elsewhere (N = 103). Recency was estimated (Wulan et al., 2023) and clinical/demographic information was obtained from protocol records.
Results
We studied 59 treatment-experienced and 19 newly-diagnosed PWH (N = 78; 37.2% female, median age 28 years (IQR1;3 = 23; 35.75)). Suspected transmission modes were MSM (26.9%), heterosexual (53.8%), perinatal (16.7%), and IDU (1.3%). DRMs were found in 94.9% of treatment-experienced PWH. Common NRTI resistance mutations included M184I/V (88.1%), K219Q/E and D67N (20.3% each), and tenofovir (TDF)-associated K65R (19.6%). NNRTI DRMs were common: Y181C/I, K103N, and G190A/S (40.7%, 30.5%, 28.8%). No DRMs were found in newly diagnosed PWH, including 6 recent infections. Bayesian inference identified groups (posterior probability ≥0.95) with diverse members, including individuals with chronic and recent infections, those with DRMs, and members located 2,000-3,000 km apart.
Conclusion
CRF01_AE spread is not geographically restricted within the large Indonesian archipelago. We found a substantial proportion of K65R in TDF-treated PWH.

Keywords: CRF01_AE, DRMs, transmission, Indonesia

Primary authors

Dr Wahyu Nawang Wulan (The Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia) Dr Wei Shao (HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, US) Dr Dona Arlinda ((1) Ministry of Health Republic of Indonesia, National Institute of Health Research and Development (NIHRD), Jakarta, Indonesia; (2) The Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia) Prof. Ketut Tuti Parwati Merati (Sanglah Hospital, Denpasar, Indonesia) Prof. Evy Yunihastuti ((1) Department of Internal Medicine, Faculty of Medicine Universitas Indonesia / Cipto Mangunkusumo Hospital, Jakarta, Indonesia; (2) HIV Integrated Clinic, Cipto Mangunkusumo Hospital, Jakarta, Indonesia) Dr Rudi Wisaksana (Dr. Hasan Sadikin Hospital, Bandung, Indonesia) Dr Nia Kurniati (Department of Pediatrics, Faculty of Medicine Universitas Indonesia / Cipto Mangunkusumo Hospital, Jakarta, Indonesia) Dr Zehava Grossman ((1) School of Public Health, University of Tel Aviv, Israel; (2) HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, US) Dr Kristi Huik ((1) Department of Microbiology, University of Tartu, Estonia; (2) HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, US) Dr Thuy Nguyen (HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, US) Dr Muhammad Karyana ((1) Ministry of Health Republic of Indonesia, National Institute of Health Research and Development (NIHRD), Jakarta, Indonesia; (2) The Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia) Dr Aaron Neal (National Institute of Allergy and Infectious Diseases, Bethesda, United States) Dr Frank Maldarelli (HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, US)

Presentation materials

There are no materials yet.